Source:http://linkedlifedata.com/resource/pubmed/id/19662337
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-5-10
|
pubmed:abstractText |
Von Willebrand factor (VWF) and tissue plasminogen activator (t-PA) predict adverse cardiovascular outcome following acute myocardial infarction (AMI) and are weakly associated with pre-discharge left ventricular ejection fraction (LVEF). We examined the relationships between VWF, t-PA antigen, matrix metalloproteinase (MMP)-2,-3, and -9, and B-type natriuretic peptide (BNP), and their predictive effect on serial change in LV volumes in a cohort of patients admitted with AMI. Plasma VWF, t-PA antigen, MMP-2,-3,-9, and BNP were measured at a mean 46 h after AMI in 100 patients (mean age 58.9 +/- 12 years, 77% male) with depressed LVEF. Cardiac magnetic resonance (CMR) imaging was then performed. Biomarker measurement and CMR were repeated at 12 and 24 weeks. Plasma concentrations of VWF, BNP and MMP-9 were elevated while t-PA antigen concentration was at the upper limits of normal; over 24 weeks VWF, t-PA antigen, MMP-9 and BNP decreased significantly. Baseline VWF correlated with BNP (r = 0.35, P < 0.001) and MMP-3 (r = 0.24, P = 0.019) as did t-PA antigen (r = 0.27, P = 0.007 for BNP; r = 0.40, P < 0.001 for MMP-3). t-PA antigen, VWF, MMP-3 and BNP were univariate predictors of LV end-systolic volume at 24 weeks; tPA antigen and BNP remained significant independent predictors on multivariate analysis. t-PA antigen and VWF are related to medium-term LV volumes after AMI, and to MMP-3. This novel link between the coagulation-fibrinolysis system and matrix turnover merits further study in understanding the pathophysiology of adverse ventricular remodeling after AMI.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinases,
http://linkedlifedata.com/resource/pubmed/chemical/Natriuretic Peptide, Brain,
http://linkedlifedata.com/resource/pubmed/chemical/Spironolactone,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator,
http://linkedlifedata.com/resource/pubmed/chemical/eplerenone,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1573-742X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
421-8
|
pubmed:meshHeading |
pubmed-meshheading:19662337-Aged,
pubmed-meshheading:19662337-Aldosterone Antagonists,
pubmed-meshheading:19662337-Biological Markers,
pubmed-meshheading:19662337-Double-Blind Method,
pubmed-meshheading:19662337-Female,
pubmed-meshheading:19662337-Humans,
pubmed-meshheading:19662337-Male,
pubmed-meshheading:19662337-Matrix Metalloproteinases,
pubmed-meshheading:19662337-Middle Aged,
pubmed-meshheading:19662337-Myocardial Infarction,
pubmed-meshheading:19662337-Natriuretic Peptide, Brain,
pubmed-meshheading:19662337-Predictive Value of Tests,
pubmed-meshheading:19662337-Spironolactone,
pubmed-meshheading:19662337-Stroke Volume,
pubmed-meshheading:19662337-Tissue Plasminogen Activator,
pubmed-meshheading:19662337-Ventricular Remodeling,
pubmed-meshheading:19662337-von Willebrand Factor
|
pubmed:year |
2010
|
pubmed:articleTitle |
Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction.
|
pubmed:affiliation |
Cardiology Department, Western Infirmary, Glasgow, Scotland, UK. robinweir75@hotmail.com
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|